Three phenotypes of obstructive lung disease in the elderly

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 11, 2010, Pages 1481-1488

  Jo, K W ^a   Ra, S W ^b   Chae, E J ^a   Seo, J B ^a   Kim, N K ^a   Lee, J H ^c,g   Kim, E K ^c   Lee, Y K ^d   Kim, T H ^e   Huh, J W ^a   Kim, W J ^f   Lee, S M ^h   Lim, S Y ⁱ   Shin, T R ^j   Yoon, H I ^k   Sheen, S S ^l   Lee, J S ^a   Lee, S D ^a   Oh, Y M ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Ulsan University College of Medicine   (South Korea)

^c CHA University   (South Korea)

^d Kyung Hee University College of Medicine   (South Korea)

^e Hanyang University Guri Hospital   (South Korea)

^f Kangwon National University   (South Korea)

^g Ewha Womans University School of Medicine   (South Korea)

^h Seoul National University Hospital   (South Korea)

ⁱ Sungkyunkwan University School of Medicine   (South Korea)

^j Hallym University College of Medicine   (South Korea)

^k Seoul National University Bundang Hospital   (South Korea)

^l Ajou University School of Medicine   (South Korea)

more..

Author keywords

Asthma; Chronic bronchitis; Elderly; Emphysema; Obstructive lung disease

Indexed keywords

BRONCHODILATING AGENT; IMMUNOGLOBULIN E; METHACHOLINE;

AGED; AGING; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLASSIFICATION; CLUSTER ANALYSIS; COMPUTED TOMOGRAPHY SCANNER; DISEASE SEVERITY; EMPHYSEMA; EXERCISE TEST; FACTORIAL ANALYSIS; FORCED EXPIRATORY VOLUME; GERIATRIC PATIENT; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PHENOTYPE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROVOCATION TEST; QUALITY OF LIFE; QUESTIONNAIRE; SOUTH KOREA; SPIROMETRY; STATISTICAL ANALYSIS;

AGED; BRONCHIAL HYPERREACTIVITY; BRONCHODILATOR AGENTS; CLUSTER ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; PHENOTYPE; REPUBLIC OF KOREA; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TOTAL LUNG CAPACITY;

EID: 78049427620     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Soriano J B, Davis K J, Coleman B, Visick G, Mannino D, Pride N B. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003; 124: 474-481.
2. Global Initiative for Asthma. Global strategy for asthma management and prevention. Bethesda, MD, USA: National Heart, Lung, and Blood Institute, National Institutes of Health, USA, and the World Health Organization, 2008. http://www.ginaasthma.org Accessed September 2009.
3. Rabe K F, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
4. Viegi G, Matteelli G, Angino A, et al. The proportional Venn diagram of obstructive lung disease in the Italian general population. Chest 2004; 126: 1093-1101.
5. Weatherall M, Travers J, Shirtcliffe P M, et al. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J 2009; 34: 812-818.
6. Calverley P M, Burge P S, Spencer S, Anderson J A, Jones P W. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58: 659-664. (Pubitemid 36976273)
7. Macnee W. Pathogenesis of chronic obstructive pulmonary disease. Clin Chest Med 2007; 28: 479-513.
8. Kim Y S, Byun M K, Jung W Y, et al. Validation of the Korean version of the St George's Respiratory Questionnaire for patients with chronic respiratory disease. Tubercle Respir Dis 2006; 61: 121-128.
9. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
10. Quanjer P H, Tammeling G J, Cotes J E, Pedersen O F, Peslin R, Yernault J C. Lung volumes and forced ventilatory flows. Report of the Working Party on the Standardization of Lung Function Tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 5-40.
11. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique: 1995 update. Am J Respir Crit Care Med 1995; 152: 2185-2198.
12. Gevenois P A, de Maertelaer V, De Vuyst P, Zanen J, Yernault J C. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995; 152: 653-657.
13. Lee Y K, Oh Y M, Lee J H, et al. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung 2008; 186: 157-165.
14. Maridia K V, Kent J T, Bibby J M. Multivariant analysis. London, UK: Academic Press, 1975.
15. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnoea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-1440. (Pubitemid 34499652)
16. Lee J S, Ra S W, Seo J B, et al. Clinical predictors of pulmonary function response to 3-month treatment in chronic obstructive pulmonary disease [Abstract]. Respirology 2009; 14 (Suppl 3): A 160.
17. Schols A M, Slangen J, Volovics L, Wouters E F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1791-1797.
18. Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 680-685. (Pubitemid 34971850)
19. Casanova C, Cote C, de Torres J P, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 591-597.
20. Pinto-Plata V M, Cote C, Cabral H, Taylor J, Celli B R. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004; 23: 28-33.
21. Nakano Y, Wong J C, de Jong P A, et al. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med 2005; 171: 142-146.
22. Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers: correlation with lung function. Am J Respir Crit Care Med 2000; 162: 1102-1108.
23. Everitt B S, Landau S, Leese M. Cluster analysis. 4th ed. London, UK: Arnold, 2001.
24. Haldar P, Pavord I D, Shaw D E, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178: 218-224.
25. Pistolesi M, Camiciottoli G, Paoletti M, et al. Identification of a predominant COPD phenotype in clinical practice. Respir Med 2008; 102: 367-376.
26. Nguyen H Q, Altinger J, Carrieri-Kohlman V, Gormley J M, Stulbarg M S. Factor analysis of laboratory and clinical measurements of dyspnoea in patients with chronic obstructive pulmonary disease. J Pain Symptom Manage 2003; 25: 118-127.
27. Lapperre T S, Snoeck-Stroband J B, Gosman M M, et al. Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170: 499-504.
28. Wegner R E, Jorres R A, Kirsten D K, Magnussen H. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J 1994; 7: 725-729. (Pubitemid 24122970)
29. Hsia C C. Recruitment of lung diffusing capacity: update of concept and application. Chest 2002; 122: 1774-1783.
30. Hay J G, Stone P, Carter J, et al. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J 1992; 5: 659-664.
31. Pineda H, Haas F, Axen K, Haas A. Accuracy of pulmonary function test in predicting exercise tolerance in chronic obstructive pulmonary disease. Chest 1984; 86: 564-567.